MAY 13, 2022 10:30 AM PDT

Multiple Mental Health Diagnoses are Increasingly Common. Why?

WRITTEN BY: Ryan Vingum

Mental illness has become increasingly common. The number of people with anxiety and depression, specifically, has steadily increased. The COVID-19 pandemic only made this worse, leading to a roughly 25% increase in the number of anxiety and depression cases.

To complicate matters, many people diagnosed with a mental health disorder are often diagnosed with others at some point in their lives. People with depression, for example, are more likely to be diagnosed with anxiety disorders within 6 months of their initial diagnosis.

This growing prevalence of comorbid psychiatric disorders can make treatment challenging and disheartening for patients. But new research examining the genetic causes of several mental health disorders may offer a glimmer of hope.


A new study published in Nature Genetics offers a look at the genetic structure underpinning several different types of mental health disorders. Specifically, researchers from the University of Colorado at Boulder used publicly available genetic data to examine 11 mental health disorders (including anxiety disorders, major depressive disorder, anorexia, and schizophrenia in search of a potential genetic “common denominator,” which they hoped might explain what’s behind this rise in mental health disorder comorbidity.

In their analysis, researchers did not find a single gene or genes that was conclusively connected to all 11 disorders. Instead, they found that certain groups of disorders (e.g., bipolar disorders, anorexia and OCD, etc.) did share some common genetic traits. 

The findings suggest that people with certain disorders may be more genetically predisposed to similar disorders in that subset, which could change the way clinicians think about, diagnose, and treat mental health disorders in the future. 

In particular, the idea that certain types of mental health conditions have similar underlying genetic causes could change the game when it comes to developing drugs and pharmaceuticals to treat them. Researchers believe their work could lead to the development of drugs designed to target several related conditions at once. This could help patients avoid taking multiple drugs and experiencing several side effects to treat multiple comorbid conditions. 

Sources: EurekaAlert!; JAMA; WHO; Nature Genetics

About the Author
Professional Writing
Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
MAR 04, 2022
Drug Discovery & Development
COVID-19 Vaccines and Treatments Less Effective Against Omicron
MAR 04, 2022
COVID-19 Vaccines and Treatments Less Effective Against Omicron
mRNA COVID-19 vaccines and monoclonal antibody treatments are less effective against Omicron sub-variants of COVID-19 th ...
APR 07, 2022
Cancer
Music Therapy Offers an Innovative Approach to Cancer Therapy
APR 07, 2022
Music Therapy Offers an Innovative Approach to Cancer Therapy
  Last month we explored the value of art therapy for cancer patients and survivors, and now we can ...
APR 20, 2022
Health & Medicine
The Link between Mental Health and COVID Breakthrough Infection
APR 20, 2022
The Link between Mental Health and COVID Breakthrough Infection
Researchers from University of California San Francisco and the San Francisco Veterans Affairs Health Care System conduc ...
MAY 17, 2022
Cancer
Looking for an Easier Way to Scale-up Your Benchtop Cell Cultures?
MAY 17, 2022
Looking for an Easier Way to Scale-up Your Benchtop Cell Cultures?
Much has been written about scaling up cell culture for bioprocessing and other applications that require a very high de ...
MAY 15, 2022
Microbiology
A Virus Was Used to Cure an Antibiotic-Resistant Lung Infection
MAY 15, 2022
A Virus Was Used to Cure an Antibiotic-Resistant Lung Infection
In a clinical first, reported in Cell, researchers used viruses that infect bacteria, called bacteriophages or phages fo ...
MAY 20, 2022
Drug Discovery & Development
Drug Shows Promise in treating Spinal Cord Injury
MAY 20, 2022
Drug Shows Promise in treating Spinal Cord Injury
A drug developed by AstraZeneca preserves 80% of nerve function following spinal cord compression injury. The correspond ...
Loading Comments...